Dapagliflozin in Patients with Chronic Kidney Disease

被引：0
|
作者：
Yasuda, Hideo [1 ]
Isobe, Shinsuke [1 ]
机构：
[1] Hamamatsu Univ Sch Med, Shizuoka, Japan
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：389 / 389
页数：1
相关论文
共 50 条
  • [1] Dapagliflozin in Patients with Chronic Kidney Disease
    Heerspink, Hiddo J. L.
    Stefansson, Bergur V.
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Greene, Tom
    Hou, Fan-Fan
    Mann, Johannes F. E.
    McMurray, John J. V.
    Lindberg, Magnus
    Rossing, Peter
    Sjostrom, C. David
    Toto, Roberto D.
    Langkilde, Anna-Maria
    Wheeler, David C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15): : 1436 - 1446
  • [2] Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease
    Patoulias, Dimitrios
    [J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (07)
  • [3] Dapagliflozin versus empagliflozin in patients with chronic kidney disease
    Alnsasra, Hilmi
    Tsaban, Gal
    Solomon, Adam
    Khalil, Fouad
    Aboalhasan, Enis
    Azab, Abed N.
    Azuri, Joseph
    Hammerman, Ariel
    Arbel, Ronen
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [4] Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease IN RESPONSE
    Schechter, Meir
    Chertow, Glenn M.
    Heerspink, Hiddo J. L.
    [J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (07) : eL230070
  • [5] Summary for Patients: Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease
    Schechter, M.
    Jongs, N.
    Chertow, G. M.
    [J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (01) : I19 - I19
  • [6] Dapagliflozin for the treatment of chronic kidney disease
    Kurata, Yu
    Nangaku, Masaomi
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (04) : 275 - 291
  • [7] An update on dapagliflozin for chronic kidney disease
    Kelly, Michael S.
    [J]. DRUGS OF TODAY, 2022, 58 (02) : 69 - 75
  • [8] Dapagliflozin (Farxiga) for Chronic Kidney Disease
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1629): : 115 - 115
  • [9] Dapagliflozin treatment in patients with chronic kidney disease associated with autosomal dominant polycystic kidney disease
    Yoshimoto, Masatoshi
    Sekine, Akinari
    Suwabe, Tatsuya
    Oba, Yuki
    Mizuno, Hiroki
    Yamanouchi, Masayuki
    Ubara, Yoshifumi
    Hoshino, Junichi
    Inoue, Noriko
    Tanaka, Kiho
    Hasegawa, Eiko
    Sawa, Naoki
    Wada, Takehiko
    [J]. CLINICAL KIDNEY JOURNAL, 2024, 17 (08)
  • [10] Dapagliflozin Improves the Clinical Outcomes of Patients with Chronic Kidney Disease and Albuminuria
    Patrick, Stephanie A.
    Dabal, Tracey D.
    Jackson, Christopher D.
    Halalau, Alexandra
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (09) : 2915 - 2917
12345